Human IGF1 pro-forms induce breast cancer cell proliferation via the IGF1 receptor
- 1.1k Downloads
IGF1 is a key regulator of tissue growth and development and has been implicated in the initiation and progression of various cancers, including breast cancer. Through IGF1 mRNA splicing different precursor pro-peptides, i.e., the IGF1Ea, IGF1Eb and IGF1Ec pro-forms, are formed whose biological roles in the pathogenesis of breast cancer have not been established yet. The objective of this study was to assess the biological activity of the IGF1 pro-forms in human breast cancer-derived cells.
The different IGF1 pro-forms were generated through transient transfection of HEK293 cells with the respective vector constructs. The resulting conditioned media were applied in vitro to MCF7, T47D and ZR751 breast cancer-derived cell cultures. The recombinant human IGF1 pro-forms were also tested for their binding affinity to an anti-IGF1 specific antibody by immunoprecipitation. To determine whether the IGF1 pro-forms induce cell proliferation, mature IGF1 was neutralised in HEK293-derived conditioned media.
We found that the IGF1 pro-forms were the only forms that were produced intra-cellularly, whereas both mature IGF1 and the IGF1 pro-forms were detected extra-cellularly. We also found that E peptides can impair the IGF1 pro-form binding affinity for the anti-IGF1 antibody and, thus, hamper an accurate measurement of the IGF1 pro-forms. Additionally, we found that the IGF1 antibody can completely inhibit IGF1-induced breast cancer cell proliferation and IGF1 receptor (IGF1R) phosphorylation, wheras the same antibody was found to only partially inhibit the biological activity of the pro-forms. Moreover, we found that the IGF1 pro-form activities can completely be inhibited by neutralising the IGF1R. Finally, we compared the bioactivity of the IGF1 pro-forms to that of mature IGF1, and found that the IGF1 pro-forms were less capable of phosphorylating the IGF1R in the breast cancer-derived cells tested.
Our data indicate that IGF1 pro-forms can induce breast cancer cell proliferation via the IGF1R, independent from the mature IGF1 form. These results underline the importance of an accurate assessment of the presence of IGF1 pro-forms within the breast cancer microenvironment.
KeywordsIGF1 pro-forms Breast cancer IGF1 receptor
The authors would like to thank Dr. Joanne Tonkin and Dr. Tommaso Nastasi for kindly providing the IGF1 pro-form specific constructs for the cell transfections.
Compliance with ethical standards
This study was supported by the RF-2009-1,532,789 Ministry of Health Project-Italy.
Conflict of interest
The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.
- 1.S. J. Weroha, P. Haluska, IGF system in cancer. Endocrinol. Metab. Clin. N. Am. 41(335–350) (2012)Google Scholar
- 3.E. Hormones, B. C. C. Group, Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol. 11, 530–542 (2010)Google Scholar
- 4.T. O. Nielsen, H. N. Andrews, M. Cheang, J. E. Kucab, F. D. Hsu, J. Ragaz, C. B. Gilks, N. Makretsov, C. D. Bajdik, C. Brookes, L. M. Neckers, V. Evdokimova, D. G. Huntsman, S. E. Dunn, Expression of the insulin-like growth factor I receptor and urokinase plasminogen activator in breast cancer is associated with poor survival: potential for intervention with 17-allylamino geldanamycin. Cancer Res. 64, 286–291 (2004)CrossRefPubMedGoogle Scholar
- 6.A. Philippou, M. Maridaki, S. Pneumaticos, M. Koutsilieris, The complexity of the IGF1 gene splicing, posttranslational modification and bioactivity. Mol. Med. 7, 202–214 (2014)Google Scholar
- 7.B. K. Brisson, E. R. Barton, New modulators for IGF-I activity within IGF-I processing products. Front. Endocrinol. 27, 42 (2013)Google Scholar
- 16.D. S. Milingos, A. Philippou, A. Armakolas, E. Papageorgiou, A. Sourla, A. Protopapas, A. Liapi, A. Antsaklis, M. Mastrominas, M. Koutsilieris, Insulinlike growth factor-1Ec (MGF) expression in eutopic and ectopic endometrium endometrium: characterization of the MGF E-peptide actions in vitro. Mol. Med. 17, 21–28 (2010)PubMedPubMedCentralGoogle Scholar
- 17.A. Armakolas, A. Philippou, Z. Panteleakou, A. Nezos, A. Sourla, C. Petraki, M. Koutsilieris, Preferential expression of IGF-1Ec (MGF) transcript in cancerous tissues of human prostate: evidence for a novel and autonomous growth factor activity of MGF E peptide in human prostate cancer cells. Prostate 70, 1233–1242 (2010)CrossRefPubMedGoogle Scholar
- 22.T. Norat, L. Dossus, S. Rinaldi, K. Overvad, H. Grønbaek, A. Tjønneland, A. Olsen, F. Clavel-Chapelon, M. C. Boutron-Ruault, H. Boeing, P. H. Lahmann, J. Linseisen, G. Nagel, A. Trichopoulou, D. Trichopoulos, V. Kalapothaki, S. Sieri, D. Palli, S. Panico, R. Tumino, C. Sacerdote, H. B. Bueno-de-Mesquita, P. H. Peeters, C. H. van Gils, A. Agudo, P. Amiano, E. Ardanoz, C. Martinez, R. Quirós, M. J. Tormo, S. Bingham, T. J. Key, N. E. Allen, P. Ferrari, N. Slimani, E. Riboli, R. Kaaks, Diet, serum insulin-like growth factor-I and IGF-binding protein-3 in European women. Eur. J. Clin. Nutr. 61, 91–98 (2007)CrossRefPubMedGoogle Scholar
- 23.L. Galluzzi, M. De Santi, R. Crinelli, C. De Marco, N. Zaffaroni, A. Duranti, G. Brandi, M. Magnani, Induction of endoplasmic reticulum stress response by the indole-3-carbinol cyclic tetrameric derivative CTet in human breast cancer cell lines. PLoS One 7, e43249 (2012)CrossRefPubMedPubMedCentralGoogle Scholar
- 24.M. De Santi, L. Galluzzi, S. Lucarini, M. F. Paoletti, A. Fraternale, A. Duranti, C. De Marco, M. Fanelli, N. Zaffaroni, G. Brandi, M. Magnani, The indole-3-carbinol cyclic tetrameric derivative CTet inhibits cell proliferation via overexpression of p21/CDKN1A in both estrogen receptor-positive and triple negative breast cancer cell lines. Breast Cancer Res. 13, R33 (2011)CrossRefPubMedPubMedCentralGoogle Scholar
- 29.M. P. Santini, L. Tsao, L. Monassier, C. Theodoropoulos, J. Carter, E. Lara-Pezzi, E. Slonimsky, E. Salimova, P. Delafontaine, Y. H. Song, M. Bergmann, C. Freund, K. Suzuki, N. Rosenthal, Enhancing repair of the mammalian heart. Circ. Res. 100, 1732–1740 (2007)CrossRefPubMedPubMedCentralGoogle Scholar
- 30.M. P. Santini, J. Lexow, G. Borsellino, E. Slonimski, E. Zarrinpashneh, T. Poggioli, N. Rosenthal, IGF-1Ea induces vessel formation after injury and mediates bone marrow and heart cross-talk through the expression of specific cytokines. Biochem. Biophys. Res. Commun. 410, 201–207 (2011)CrossRefPubMedGoogle Scholar